Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Linezolid.

Manish Narang1, Sunil Gomber

  • 1Department of Pediatrics, University College of Medical Sciences and GTB Hospital, Delhi-110 095, India.

Indian Pediatrics
|December 14, 2004
PubMed
Summary
This summary is machine-generated.

Linezolid is an oxazolidinone antibiotic that effectively inhibits bacterial protein synthesis. It shows broad-spectrum activity against resistant gram-positive bacteria and is well-tolerated in children, offering oral bioavailability for serious infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety, Immunogenicity of Co-Administered Vaccines, and Lot-to-Lot Consistency of a 14-Valent Pneumococcal Conjugate Vaccine (PNEUBEVAX 14<sup>®</sup>) Administered at 6-10-14 Weeks in Healthy Infants: A Multicenter, Phase IV Trial.

Vaccines·2026
Same author

Proteinuria and gall bladder wall thickness as predictive indicators for dengue severity in pediatric patients.

Paediatrics & child health·2026
Same author

Immunogenicity and safety of biological E's 14-valent pneumococcal conjugate vaccine (PNEUBEVAX 14®) administered in a 2p + 1 schedule to healthy infants: a multicenter, randomized, active controlled, single-blind, phase III trial.

The Lancet regional health. Southeast Asia·2026
Same author

Effect of Valproate on Serum BDNF and MMP-9 in Pediatric Epilepsy.

Journal of epilepsy research·2025
Same author

Real-world study to compare functional SYNTAX score versus anatomical SYNTAX score in influencing the treatment strategy for multivessel disease patients.

Scientific reports·2025
Same author

Levetiracetam Monotherapy and its Combination with Phenytoin: Exploring Novel Biomarkers in Pediatric Epilepsy.

Current neurovascular research·2025
Same journal

Microbial Conversations Between the Gut and Urinary Tract: Emerging Implications for Kidney and Urinary Tract Diseases.

Indian pediatrics·2026
Same journal

Prevalence and Associated Social Factors of Prediabetes in Children and Adolescents in India: A Systematic Review and Meta-Analysis.

Indian pediatrics·2026
Same journal

Comparison of Early Intrapleural Fibrinolytic Therapy, Versus Administration After Failure of Intercostal Drainage in Children with Empyema Thoracis: A Systematic Review.

Indian pediatrics·2026
Same journal

Can Nebulized Epinephrine Prevent Extubation Failure in Neonates?

Indian pediatrics·2026
Same journal

Pragmatic Respiratory Stabilization During Neonatal Intubation-What Does this Trial Add for Indian NICUs?

Indian pediatrics·2026
Same journal

Universal Early-Life Screening in India: Time for a National Integrated Strategy.

Indian pediatrics·2026
See all related articles

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Linezolid is a key oxazolidinone antibiotic.
  • Bacterial protein synthesis is a critical target for antibiotics.
  • Gram-positive infections pose significant treatment challenges.

Purpose of the Study:

  • To summarize the antibacterial profile of linezolid.
  • To highlight its efficacy against resistant pathogens.
  • To discuss its pharmacokinetic properties and tolerability.

Main Methods:

  • Review of linezolid's mechanism of action.
  • Analysis of its spectrum of activity.
  • Evaluation of its oral bioavailability and tolerability.

Main Results:

Related Experiment Videos

  • Linezolid inhibits bacterial protein synthesis initiation.
  • It is effective against methicillin-resistant Staphylococcus, penicillin-resistant Streptococcus pneumoniae, and vancomycin-resistant Enterococcus.
  • Linezolid demonstrates good oral bioavailability and is well-tolerated in pediatric patients.

Conclusions:

  • Linezolid is a valuable therapeutic option for serious gram-positive infections.
  • Its oral bioavailability allows for effective step-down therapy.
  • The drug is safe and effective in children.